Dianthus Therapeutics, Inc. (DNTH)

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $2.26M in the twelve months ending March 31, 2024, down -20.15% year-over-year. Revenue in the quarter ending March 31, 2024 was $874.00K with 83.61% year-over-year growth. In the year 2023, Dianthus Therapeutics had annual revenue of $2.83M, a decrease of -55.96%.

• Revenue (ttm): $2.26M
• Revenue Growth: -20.15%
• P/S Ratio: 341.91
• Revenue / Employee: $42,547
• Employees: 53
• Market Cap: 771.01M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.83M	-3.59M	-55.96%
Dec 31, 2022	6.42M	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.